Effects of sacubitril valsartan on clinical and echocardiographic parameters of outpatients with heart failure and reduced ejection fraction

AIM: Sacubitril valsartan (SV) has revolutionized disease history in patients with heart failure and reduced ejection fraction (HFrEF). Our study assessed SV impact on clinical and echocardiographic parameters in HFrEF outpatients previously treated with optimized therapy. METHODS: Forty-nine HFrEF...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Cardiol Heart Vasc
Autors principals: Landolfo, Matteo, Piani, Federica, Esposti, Daniela Degli, Cosentino, Eugenio, Bacchelli, Stefano, Dormi, Ada, Borghi, Claudio
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2020
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586107/
https://ncbi.nlm.nih.gov/pubmed/33134479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijcha.2020.100656
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars